Daiwa Securities Group Inc. Medicinova Inc Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$2.61 - $4.42 $219 - $371	-84 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$5.03 - $6.31 $422 - $530	84 New	84 $0
Q4 2019 Jan 31, 2020	SELL	$6.48 - $8.76 $1,736 - $2,347	-268 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$6.82 - $10.27 $2,264 - $3,409	-332 Reduced 55.33%	268 $2,000
Q4 2018 Feb 05, 2019	BUY	$7.65 - $12.83 $4,590 - $7,698	600 New	600 $5,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $104M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.